221 related articles for article (PubMed ID: 19561325)
1. Rodent and nonrodent malaria parasites differ in their phospholipid metabolic pathways.
Déchamps S; Maynadier M; Wein S; Gannoun-Zaki L; Maréchal E; Vial HJ
J Lipid Res; 2010 Jan; 51(1):81-96. PubMed ID: 19561325
[TBL] [Abstract][Full Text] [Related]
2. A pathway for phosphatidylcholine biosynthesis in Plasmodium falciparum involving phosphoethanolamine methylation.
Pessi G; Kociubinski G; Mamoun CB
Proc Natl Acad Sci U S A; 2004 Apr; 101(16):6206-11. PubMed ID: 15073329
[TBL] [Abstract][Full Text] [Related]
3. Disruption of the Plasmodium falciparum PfPMT gene results in a complete loss of phosphatidylcholine biosynthesis via the serine-decarboxylase-phosphoethanolamine-methyltransferase pathway and severe growth and survival defects.
Witola WH; El Bissati K; Pessi G; Xie C; Roepe PD; Mamoun CB
J Biol Chem; 2008 Oct; 283(41):27636-27643. PubMed ID: 18694927
[TBL] [Abstract][Full Text] [Related]
4. The origins, isolation, and biological characterization of rodent malaria parasites.
Pattaradilokrat S; Wu J; Xu F; Su XZ
Parasitol Int; 2022 Dec; 91():102636. PubMed ID: 35926694
[TBL] [Abstract][Full Text] [Related]
5. In vivo evidence for the specificity of Plasmodium falciparum phosphoethanolamine methyltransferase and its coupling to the Kennedy pathway.
Pessi G; Choi JY; Reynolds JM; Voelker DR; Mamoun CB
J Biol Chem; 2005 Apr; 280(13):12461-6. PubMed ID: 15664981
[TBL] [Abstract][Full Text] [Related]
6. Computational and experimental elucidation of Plasmodium falciparum phosphoethanolamine methyltransferase inhibitors: Pivotal drug target.
Singh J; Vijay S; Mansuri R; Rawal R; Kadian K; Sahoo GC; Kumar M; Sharma A
PLoS One; 2019; 14(8):e0221032. PubMed ID: 31437171
[TBL] [Abstract][Full Text] [Related]
7. Plasmodium vinckei genomes provide insights into the pan-genome and evolution of rodent malaria parasites.
Ramaprasad A; Klaus S; Douvropoulou O; Culleton R; Pain A
BMC Biol; 2021 Apr; 19(1):69. PubMed ID: 33888092
[TBL] [Abstract][Full Text] [Related]
8. The Consequences of Mixed-Species Malaria Parasite Co-Infections in Mice and Mosquitoes for Disease Severity, Parasite Fitness, and Transmission Success.
Tang J; Templeton TJ; Cao J; Culleton R
Front Immunol; 2019; 10():3072. PubMed ID: 32038623
[TBL] [Abstract][Full Text] [Related]
9. On the genetics of malaria parasites, a memoir: Part II, the diversity and phylogeny of the rodent malaria parasites.
Carter R
Parasitol Int; 2022 Dec; 91():102650. PubMed ID: 36038058
[TBL] [Abstract][Full Text] [Related]
10. Evolution of the Phosphatidylcholine Biosynthesis Pathways in Green Algae: Combinatorial Diversity of Methyltransferases.
Hirashima T; Toyoshima M; Moriyama T; Sato N
J Mol Evol; 2018 Jan; 86(1):68-76. PubMed ID: 29330556
[TBL] [Abstract][Full Text] [Related]
11. Cloning, expression and functional characterization of heme detoxification protein (HDP) from the rodent malaria parasite Plasmodium vinckei.
Soni A; Goyal M; Prakash K; Bhardwaj J; Siddiqui AJ; Puri SK
Gene; 2015 Jul; 566(1):109-19. PubMed ID: 25891072
[TBL] [Abstract][Full Text] [Related]
12. The phylogeny of rodent malaria parasites: simultaneous analysis across three genomes.
Perkins SL; Sarkar IN; Carter R
Infect Genet Evol; 2007 Jan; 7(1):74-83. PubMed ID: 16765106
[TBL] [Abstract][Full Text] [Related]
13. Defining species specific genome differences in malaria parasites.
Liew KJ; Hu G; Bozdech Z; Peter PR
BMC Genomics; 2010 Feb; 11():128. PubMed ID: 20175934
[TBL] [Abstract][Full Text] [Related]
14. Contribution of the precursors and interplay of the pathways in the phospholipid metabolism of the malaria parasite.
Wein S; Ghezal S; Buré C; Maynadier M; Périgaud C; Vial HJ; Lefebvre-Tournier I; Wengelnik K; Cerdan R
J Lipid Res; 2018 Aug; 59(8):1461-1471. PubMed ID: 29853527
[TBL] [Abstract][Full Text] [Related]
15. Reduced glycerol incorporation into phospholipids contributes to impaired intra-erythrocytic growth of glycerol kinase knockout Plasmodium falciparum parasites.
Naidoo K; Coetzer TL
Biochim Biophys Acta; 2013 Nov; 1830(11):5326-34. PubMed ID: 23954205
[TBL] [Abstract][Full Text] [Related]
16. In silico identification of genetically attenuated vaccine candidate genes for Plasmodium liver stage.
Kumar H; Frischknecht F; Mair GR; Gomes J
Infect Genet Evol; 2015 Dec; 36():72-81. PubMed ID: 26348884
[TBL] [Abstract][Full Text] [Related]
17. Kinetic modelling of phospholipid synthesis in Plasmodium knowlesi unravels crucial steps and relative importance of multiple pathways.
Sen P; Vial HJ; Radulescu O
BMC Syst Biol; 2013 Nov; 7():123. PubMed ID: 24209716
[TBL] [Abstract][Full Text] [Related]
18. Heterologous immunity in rodent malaria: comparison of the degree of cross-immunity generated by vaccination with that produced by exposure to live infection.
McColm AA; Dalton L
Ann Trop Med Parasitol; 1983 Aug; 77(4):355-77. PubMed ID: 6357121
[TBL] [Abstract][Full Text] [Related]
19. ICAM-1 is a key receptor mediating cytoadherence and pathology in the Plasmodium chabaudi malaria model.
Cunningham DA; Lin JW; Brugat T; Jarra W; Tumwine I; Kushinga G; Ramesar J; Franke-Fayard B; Langhorne J
Malar J; 2017 May; 16(1):185. PubMed ID: 28468674
[TBL] [Abstract][Full Text] [Related]
20. Rhop-3 protein conservation among Plasmodium species and induced protection against lethal P. yoelii and P. berghei challenge.
Wang T; Fujioka H; Drazba JA; Sam-Yellowe TY
Parasitol Res; 2006 Aug; 99(3):238-52. PubMed ID: 16541261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
